Antimalarial drug resistence and artemisinin based combination therapy : a bio-economic model for elucidating policy choices
Antimalarial drug resistance is a major cause of the increasing burden due to P. falciparum malaria. Artemisinin-based combination therapies (ACTs) are now recognised to be the ideal choice for the first-line treatment of uncomplicated malaria, in order to achieve two beneficial outcomes: improvemen...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
London School of Hygiene and Tropical Medicine (University of London)
2006
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.429187 |